Preclinical studies

In order to gain approval for general medical use, the quality, safety and efficacy of any product must be demonstrated. Demonstration of conformance to these requirements, particularly safety and efficacy, is largely attained by undertaking clinical trials. However, preliminary data, especially safety data, must be obtained prior to the drug's administration to human volunteers. Regulatory authority approval to commence clinical trials is based largely upon preclinical pharmacological and toxicological assessment of the potential new drug in animals. Such preclinical studies can take up to 3 years to complete, and at a cost of anywhere between US$10 million and US$30 million. On average, approximately 10 per cent of potential new drugs survive preclinical trials.

In many instances, there is no strict set of rules governing the range of tests that must be undertaken during preclinical studies. However, guidelines are usually provided by regulatory authorities. The range of studies generally undertaken with regard to traditional chemical-based pharmaceuticals is summarized in Table 4.2. Most of these tests are equally applicable to biop-harmaceutical products.

10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook


Post a comment